Biotechnology Fund Fcpr serves as Executive at SCYNEXIS INC, where they oversee executive responsibilities. Since joining the company, Biotechnology Fund Fcpr has executed 8 insider transactions totaling $500.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 7, 2014 involved exercising options for 46,863 shares valued at $0.
Biotechnology Fund Fcpr currently holds 83,363 shares of SCYNEXIS INC (SCYX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biotechnology Fund Fcpr has been a net buyer of SCYX stock. They have purchased $500.0K and sold $0 worth of shares.
Biotechnology Fund Fcpr's most recent insider trade was on May 7, 2014, when they sold 46,863 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.20 |
| Discretionary |
| May 7, 2014 | SCYX | $0 | Conversion | 88,796 | $N/A | Discretionary |
| May 7, 2014 | SCYX | $0 | Conversion | 42,336 | $N/A | Discretionary |
| May 7, 2014 | SCYX | $5.2K | Exercise | 25,998 | $0.20 | Discretionary |
| May 7, 2014 | SCYX | $1.1K | Exercise | 5,251 | $0.20 | Discretionary |
| May 7, 2014 | SCYX | $0 | Conversion | 30,582 | $N/A | Discretionary |
| May 7, 2014 | SCYX | $500.0K | Purchase | 50,000 | $10.00 | Discretionary |